DE69523912D1 - Flubendazole-kautabletten für haustiere - Google Patents

Flubendazole-kautabletten für haustiere

Info

Publication number
DE69523912D1
DE69523912D1 DE69523912T DE69523912T DE69523912D1 DE 69523912 D1 DE69523912 D1 DE 69523912D1 DE 69523912 T DE69523912 T DE 69523912T DE 69523912 T DE69523912 T DE 69523912T DE 69523912 D1 DE69523912 D1 DE 69523912D1
Authority
DE
Germany
Prior art keywords
flubendazole
pct
pets
chewable tablets
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69523912T
Other languages
English (en)
Other versions
DE69523912T2 (de
Inventor
Marie Jans
Marie Gilis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of DE69523912D1 publication Critical patent/DE69523912D1/de
Application granted granted Critical
Publication of DE69523912T2 publication Critical patent/DE69523912T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
    • A23K10/38—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material from distillers' or brewers' waste
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87—Re-use of by-products of food processing for fodder production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69523912T 1994-05-20 1995-05-12 Flubendazole-kautabletten für haustiere Expired - Lifetime DE69523912T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94201434 1994-05-20
PCT/EP1995/001801 WO1995031963A1 (en) 1994-05-20 1995-05-12 Chewable flubendazole tablets for companion animals

Publications (2)

Publication Number Publication Date
DE69523912D1 true DE69523912D1 (de) 2001-12-20
DE69523912T2 DE69523912T2 (de) 2002-06-27

Family

ID=8216895

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69523912T Expired - Lifetime DE69523912T2 (de) 1994-05-20 1995-05-12 Flubendazole-kautabletten für haustiere

Country Status (23)

Country Link
US (1) US5824336A (de)
EP (1) EP0760648B1 (de)
JP (1) JPH10501211A (de)
AT (1) ATE208611T1 (de)
AU (1) AU690994B2 (de)
BR (1) BR9507637A (de)
CA (1) CA2190357C (de)
CY (1) CY2255B1 (de)
CZ (1) CZ290406B6 (de)
DE (1) DE69523912T2 (de)
DK (1) DK0760648T3 (de)
ES (1) ES2167436T3 (de)
FI (1) FI118324B (de)
HK (1) HK1010695A1 (de)
HU (1) HU225958B1 (de)
IL (1) IL113782A (de)
NO (1) NO313402B1 (de)
NZ (1) NZ285766A (de)
PL (1) PL185332B1 (de)
PT (1) PT760648E (de)
SI (1) SI0760648T1 (de)
WO (1) WO1995031963A1 (de)
ZA (1) ZA954128B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2317560A (en) * 1996-09-20 1998-04-01 Edmund John Hilary Campion Anti-parasite medication for pets
AU7595300A (en) * 1999-09-22 2001-04-24 Akzo Nobel N.V. Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
US20050271708A1 (en) * 2002-03-05 2005-12-08 Thombre Avinash G Palatable controlled-release formulation for companion animals
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
EP1759692A3 (de) * 2003-03-10 2007-09-12 Novartis AG Geschmacksüberdeckte feste arzneiformen für Tiere
GB2399752A (en) * 2003-03-26 2004-09-29 Micap Plc Pharmaceutical composition comprising a fungal cell or cell fragment as adjuvant
AR045142A1 (es) * 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
DK1660104T3 (da) * 2003-08-26 2010-06-21 Shire Holdings Ag Farmaceutisk formulering indeholdende lanthanforbindelser
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
DE102004011512B4 (de) * 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
EP1579862A1 (de) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Verwendung von PDE III Ihibitoren zur Reduktion der Herzgrösse in an Herzversagen leidenden Säugern
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
US7348027B2 (en) * 2005-04-08 2008-03-25 Bayer Healthcare Llc Taste masked veterinary formulation
EP1920785A1 (de) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Pimobendan-Cyclodextrin Komplex enthaltendes flüssiges Präparat
WO2010132286A1 (en) * 2009-05-12 2010-11-18 Wyeth Llc Orally administered tablet formulation of an antianxiolytic compound
MD20170009A2 (ro) 2012-02-06 2017-07-31 Merial Limited Compoziţii veterinare antiparazitare orale cu conţinut de agenţi activi cu acţiune sistemică, metode şi aplicări ale acestora
EP2825159B1 (de) 2012-03-15 2022-06-22 Boehringer Ingelheim Vetmedica GmbH Pharmazeutische tablettenformulierung für die veterinärmedizinische branche, herstellungsverfahren und verwendung dafür
CN109010296A (zh) 2012-04-04 2018-12-18 英特维特国际股份有限公司 异噁唑啉化合物的固体口服药物组合物
CA2906295C (en) 2013-03-15 2019-01-22 Argenta Manufacturing Limited Chewable formulation
KR102455648B1 (ko) 2013-07-19 2022-10-19 베링거잉겔하임베트메디카게엠베하 보존된 에테르화된 사이클로덱스트린 유도체 함유 액체 수성 약제학적 조성물
JP6117079B2 (ja) * 2013-10-01 2017-04-19 富士フイルム株式会社 チュアブル錠用組成物及びチュアブル錠
US20150164047A1 (en) * 2013-11-07 2015-06-18 Urban Pet Haus, LLC Edible cat toy
BR112016011111B1 (pt) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE944581C (de) * 1953-10-15 1956-06-21 Waldhof Zellstoff Fab Verfahren zur Herstellung einer Pilengrundmasse
AU5957480A (en) * 1979-07-26 1981-01-29 American Cyanamid Company Diethyl carbamazine resinate
US4578268A (en) * 1979-07-26 1986-03-25 American Cyanamid Company Diethylcarbamazine resinate and styrylpyridinium resinate-diethylcarbamazine resinate edible anthelmintic tablets for companion animals
JPS5821615A (ja) * 1981-07-29 1983-02-08 Fujisawa Pharmaceut Co Ltd 草食獣の肝蛭症の予防治療剤
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
FR2623976B1 (fr) * 1987-12-08 1994-02-25 So Ge Val Comprime pour animal domestique

Also Published As

Publication number Publication date
BR9507637A (pt) 1997-10-07
HU9603215D0 (en) 1997-01-28
CZ290406B6 (cs) 2002-07-17
EP0760648A1 (de) 1997-03-12
NO313402B1 (no) 2002-09-30
HUT74988A (en) 1997-03-28
FI964623A0 (fi) 1996-11-19
NZ285766A (en) 1997-09-22
PL317227A1 (en) 1997-03-17
CA2190357A1 (en) 1995-11-30
IL113782A (en) 1999-08-17
JPH10501211A (ja) 1998-02-03
SI0760648T1 (en) 2002-04-30
CA2190357C (en) 2007-04-17
US5824336A (en) 1998-10-20
CZ333596A3 (en) 1997-02-12
AU690994B2 (en) 1998-05-07
ATE208611T1 (de) 2001-11-15
EP0760648B1 (de) 2001-11-14
NO964912L (no) 1996-11-19
IL113782A0 (en) 1995-08-31
PT760648E (pt) 2002-04-29
ES2167436T3 (es) 2002-05-16
HK1010695A1 (en) 1999-06-25
NO964912D0 (no) 1996-11-19
DE69523912T2 (de) 2002-06-27
ZA954128B (en) 1996-11-19
WO1995031963A1 (en) 1995-11-30
HU225958B1 (en) 2008-01-28
FI118324B (fi) 2007-10-15
AU2527295A (en) 1995-12-18
CY2255B1 (en) 2003-07-04
FI964623A (fi) 1996-11-19
DK0760648T3 (da) 2002-02-25
PL185332B1 (pl) 2003-04-30

Similar Documents

Publication Publication Date Title
DE69523912T2 (de) Flubendazole-kautabletten für haustiere
BR9406362A (pt) Composto,processo para a preparação do mesmo e composição anti-nuclear
BRPI0507801A (pt) compostos de azetidina substituìda, processo para a preparação de compostos de azetidina substituìda, medicamento e uso de pelo menos um composto de azetidina substituìda
AU7285487A (en) Anthelmintic quaternaryalkyl acylhydrazones, method of use and compositions
BR0215277A (pt) Dicetopiperazinas substituìdas como antagonistas da oxitocina
BR0013313A (pt) Derivados substituìdos de pirrolidino-2,3,4- triona-3-oxina eficazes como antagonistas de receptores de nmda
BR0311970A (pt) Novos compostos, seu uso e preparação
MX2007003307A (es) 4-bencil-1,3-dihidro-imidazol-2-tionas substituidas y no substituidas que actuan como agonistas adrenergicos alfa2 especificos o selectivos y metodos de uso de las mismas.
BR9612196A (pt) Tiazolinas substituidas
DE3776336D1 (de) Anthelmintische acylhydrazone verfahren zur verwendung und zusammensetzungen.
MX9605709A (es) Tabletas masticables de flubendazol para animales de compañia.
SE8302283D0 (sv) Heterocykliska aminodinosubstituerade ureauforeningar och deras farmaceutiska anvendning
GB0003234D0 (en) Method of treatment
ATE247649T1 (de) Disubstituierte biphenyloxazoline
TW200510379A (en) 1, 4-disubstituted piperidine compounds, their preparation and use as medicaments
PT1308446E (pt) 5-(alquilideno-cicloalquil) - e 5-(alquilideno- heterociclil) pirazoles
WO2003037335A8 (en) 5-heteroatom-substituted pyrazoles
ES2140683T3 (es) Procedimiento para preparar compuestos de benzopirano.
ATE148342T1 (de) Verwendung von dioxapyrrolomycin als antiparasitisches mittel und dafür verwendbare zusammensetzung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition